Trademark applications and grants for Boehringer Ingelheim I N T G M B H. Boehringer Ingelheim I N T G M B H has 1136 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
Imidazopyrazine Derivatives and the Use Thereof as Medicament 20220306637 - 17/616205 GIOVANNINI; Riccardo ;   et al. | 2022-09-29 |
BIOMARKERS ASSOCIATED WITH ANTI-IL-36R ANTIBODY TREATMENT IN GENERALIZED PUSTULAR PSORIASIS 20220290239 - 17/691486 BAUM; Patrick ;   et al. | 2022-09-15 |
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF 20220288012 - 17/831460 von EYNATTEN; Maximilian ;   et al. | 2022-09-15 |
PHARMACEUTICAL COMPOSITION AND USES THEREOF 20220287980 - 17/831459 ITO; Masanori ;   et al. | 2022-09-15 |
METHODS FOR THE TREATMENT OF GPP 20220281987 - 17/685423 HALL; David B. ;   et al. | 2022-09-08 |
SEC | 0000938017 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.